The FDA has granted breakthrough therapy designation to BCB-276 for the treatment of diffuse intrinsic pontine glioma (DIPG), an incurable pediatric brain tumor. BCB-276 is an investigational chimeric ...

The definite diagnosis of CAA relies on histopathological analysis from brain autopsy or biopsy samples. Nonetheless, probable diagnosis could be inferred according to the Boston criteria, based on ...

Each interval included brain MRI (3D FLAIR, axial T2, axial PD) and SC MRI (sagittal T2, PSIR, axial T2*w, 3D T1) at 2 time points to detect new lesions and classify intervals as symptomatic or ...